Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1600 participants
OBSERVATIONAL
2009-10-31
2010-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Schizophrenic outpatients
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AstraZeneca
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
AstraZeneca
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Attila Németh
Role: PRINCIPAL_INVESTIGATOR
National Psychiatric Centre
Lilla Szabó
Role: STUDY_CHAIR
AstraZeneca Hungary MC
Tamás Bábel
Role: STUDY_DIRECTOR
AstraZeneca Hungary MC
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Research Site
Baja, , Hungary
Research Site
Barcs, , Hungary
Research Site
Budapest, , Hungary
Research Site
Cegléd, , Hungary
Research Site
Debrecen, , Hungary
Research Site
Dombóvár, , Hungary
Research Site
Dunaújváros, , Hungary
Research Site
Eger, , Hungary
Research Site
Egerszalók, , Hungary
Research Site
Emőd, , Hungary
Research Site
Esztergom, , Hungary
Research Site
Érd, , Hungary
Research Site
Gödöllő, , Hungary
Research Site
Gyöngyös, , Hungary
Research Site
Győr, , Hungary
Research Site
Gyula, , Hungary
Research Site
Heves, , Hungary
Research Site
Hódmezővásárhely, , Hungary
Research Site
Jánoshalma, , Hungary
Research Site
Jászberény, , Hungary
Research Site
Kalocsa, , Hungary
Research Site
Kecskemét, , Hungary
Research Site
Kétegyháza, , Hungary
Research Site
Kiskunhalas, , Hungary
Research Site
Kistokaj, , Hungary
Research Site
Miskolc, , Hungary
Research Site
Nagyatád, , Hungary
Research Site
Nagykanizsa, , Hungary
Research Site
Nagykálló, , Hungary
Research Site
Nagykőrös, , Hungary
Research Site
Orosháza, , Hungary
Research Site
Pécs, , Hungary
Research Site
Pomáz, , Hungary
Research Site
Sátoraljaújhely, , Hungary
Research Site
Soltvadkert, , Hungary
Research Site
Sopron, , Hungary
Research Site
Sümeg, , Hungary
Research Site
Szeged, , Hungary
Research Site
Szeghalom, , Hungary
Research Site
Szekszárd, , Hungary
Research Site
Szentes, , Hungary
Research Site
Székesfehérvár, , Hungary
Research Site
Szigetszentmiklós, , Hungary
Research Site
Szigetvár, , Hungary
Research Site
Szolnok, , Hungary
Research Site
Szombathely, , Hungary
Research Site
Tatabánya, , Hungary
Research Site
Veszprém, , Hungary
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NIS-NHU-SER-2009/1
Identifier Type: -
Identifier Source: org_study_id